Given that NSCLC cell viability did not decrease following siRNA transfection to reduce CD47 expression, it appears that the treatment-dependent reductions in cell migration and invasion can occur without cytotoxicity. The gene discussed is CD47; the disease is non-small cell lung carcinoma.